{"sent_idx": "151", "frame_idx": "7", "ev": "The probiotic group scored significantly higher on the IBS-SSS at baseline (median = 105) than the placebo group (median = 75) (Mann\u2013Whitney U test), U = 558.5, Z = \u22122.17, p < 0.05.", "icos": [["1", "placebo", "probiotic", "IBS - SSS"]], "sample": "x"}
{"sent_idx": "7", "frame_idx": "0", "ev": "At end-point, 9 (23%) of those in the probiotic group showed a \u2a7e60% change on the Montgomery\u2013A\u030asberg Depression Rating Scale (responders), compared to 10 (26%) of those in the placebo group (\u03c712=0.107, p = ns).", "icos": [["0.99879444", "placebo", "probiotic formula", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9985297", "placebo", "probiotic formulation containing L . helveticus and B . longum", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9984889", "placebo", "probiotic bacteria", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9983157", "placebo", "probiotics", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9981042", "placebo", "probiotic supplements", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"]], "sample": "c"}
{"sent_idx": "20", "frame_idx": "2", "ev": "At end-point, 9 (23%) of those in the probiotic group showed a \u2a7e60% change on the Montgomery\u2013A\u030asberg Depression Rating Scale (responders), compared to 10 (26%) of those in the placebo group (\u03c712=0.107, p = ns).", "icos": [["0.99879444", "placebo", "probiotic formula", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9985297", "placebo", "probiotic formulation containing L . helveticus and B . longum", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9984889", "placebo", "probiotic bacteria", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9983157", "placebo", "probiotics", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"], ["0.9981042", "placebo", "probiotic supplements", "Montgomery \u2013 A \u030a sberg Depression Rating Scale"]], "sample": "c"}
{"sent_idx": "150", "frame_idx": "5", "ev": "There was a significant imbalance in history of antidepressant usage, with 70% of the probiotic group self-reporting prior antidepressant usage compared with 46% of the placebo group, \u03c712=4.617, p < 0.05.", "icos": [["0.99765414", "placebo", "probiotic formula", "prior antidepressant usage"], ["0.99689543", "placebo", "probiotics", "prior antidepressant usage"], ["0.9968585", "placebo", "Lactobacillus helveticus", "prior antidepressant usage"], ["0.9958514", "placebo", "probiotic supplements", "prior antidepressant usage"], ["0.9955056", "placebo", "L . helveticus and B . longum", "prior antidepressant usage"]], "sample": "c"}
{"sent_idx": "150", "frame_idx": "6", "ev": "There was a significant imbalance in history of antidepressant usage, with 70% of the probiotic group self-reporting prior antidepressant usage compared with 46% of the placebo group, \u03c712=4.617, p < 0.05.", "icos": [["0.99762076", "placebo", "probiotic formula", "history of antidepressant usage"], ["0.99746335", "placebo", "probiotics", "history of antidepressant usage"], ["0.9966162", "placebo", "Lactobacillus helveticus", "history of antidepressant usage"], ["0.9965611", "placebo", "probiotic supplements", "history of antidepressant usage"], ["0.9956864", "placebo", "L . helveticus and B . longum", "history of antidepressant usage"]], "sample": "c"}
{"sent_idx": "176", "frame_idx": "9", "ev": "At end-point, 9 (23%) of those in the probiotic group showed a \u2a7e60% change on the MADRS (responders), compared to 10 (26%) of those in the placebo group (\u03c712=0.107, p = ns).", "icos": [["0.9990439", "placebo", "probiotic formula", "MADRS"], ["0.9990018", "placebo", "probiotics or placebo", "MADRS"], ["0.9989442", "placebo", "probiotics", "MADRS"], ["0.99876887", "placebo", "probiotic and placebo )", "MADRS"], ["0.9986929", "placebo", "Lactobacillus helveticus", "MADRS"]], "sample": "c"}
{"sent_idx": "188", "frame_idx": "11", "ev": "There were no significant differences in biomarker levels between the active treatment and placebo groups at baseline.", "icos": [["0.97245544", "placebo", "hsCRP", "biomarker levels"], ["0.96633", "placebo", "probiotic supplements", "biomarker levels"], ["0.9575305", "placebo", "placebo - controlled", "biomarker levels"], ["0.95002323", "placebo", "probiotic bacteria", "biomarker levels"], ["0.94077265", "placebo", "psychological therapy", "biomarker levels"]], "sample": "c"}
{"sent_idx": "223", "frame_idx": "18", "ev": "During the study period, there were no group differences in rates of alcohol misusers (defined as more than two standard drinks per day for women and three standard drinks per day for men; n = 4 [10%] for probiotic group, n = 2 [5%] for placebo group; p = ns), smokers (n = 8 [20%] for probiotic group, n = 10 [35%] for placebo group; p = ns) or cannabis users (n = 6 [15%] for probiotic group, n = 3 [10%] for placebo group; p = ns).", "icos": [["0.99841356", "placebo", "probiotics", "rates of alcohol misusers"], ["0.9980082", "placebo", "probiotics or placebo", "rates of alcohol misusers"], ["0.9950088", "placebo", "probiotic", "rates of alcohol misusers"], ["0.9950088", "placebo", "Probiotic", "rates of alcohol misusers"], ["0.99438226", "placebo", "active probiotic", "rates of alcohol misusers"]], "sample": "c"}
{"sent_idx": "223", "frame_idx": "19", "ev": "During the study period, there were no group differences in rates of alcohol misusers (defined as more than two standard drinks per day for women and three standard drinks per day for men; n = 4 [10%] for probiotic group, n = 2 [5%] for placebo group; p = ns), smokers (n = 8 [20%] for probiotic group, n = 10 [35%] for placebo group; p = ns) or cannabis users (n = 6 [15%] for probiotic group, n = 3 [10%] for placebo group; p = ns).", "icos": [["0.9985172", "placebo", "probiotics or placebo", "cannabis users"], ["0.9975916", "placebo", "probiotics", "cannabis users"], ["0.9969789", "placebo", "active probiotic", "cannabis users"], ["0.9968034", "placebo", "probiotic formula", "cannabis users"], ["0.9947813", "placebo", "probiotic", "cannabis users"]], "sample": "c"}
{"sent_idx": "155", "frame_idx": "8", "ev": "Characteristic Probiotic group ( n \u2009=\u200940) Placebo group ( n \u2009=\u200939) ", "icos": [["0.9989483", "Probiotic", "Placebo", "rates of alcohol misusers"], ["0.99883705", "Probiotic", "Placebo", "attention - deficit / hyperactivity disorder ( ADHD"], ["0.9987225", "Probiotic", "Placebo", "Probiotic Placebo Difference"], ["0.99867237", "Probiotic", "Placebo", "Irritable Bowel Syndrome Symptom Severity Scale"], ["0.99860746", "Probiotic", "Placebo", "Date of birth , ethnicity , household income , occupation and highest educational qualification"]], "sample": "o"}
{"sent_idx": "219", "frame_idx": "16", "ev": "Probiotic group ( n \u2009=\u200940) Placebo group ( n \u2009=\u200939) ", "icos": [["0.9992273", "Probiotic", "Placebo", "Probiotic Placebo Difference"], ["0.99915385", "Probiotic", "Placebo", "rates of alcohol misusers"], ["0.99912006", "Probiotic", "Placebo", "Irritable Bowel Syndrome Symptom Severity Scale"], ["0.9991062", "Probiotic", "Placebo", "Constipation"], ["0.9990613", "Probiotic", "Placebo", "Adverse events"]], "sample": "o"}
{"sent_idx": "264", "frame_idx": "24", "ev": "Baseline vitamin D had no effect on responding in the placebo group.", "icos": [["9.7471944e-05", "placebo", "vitamin D", "marker of inflammation ( CRP , IL - 1\u03b2 , IL - 6 or TNF - \u03b1 )"], ["9.502793e-05", "placebo", "vitamin D", "high - sensitivity C - reactive protein ( hsCRP ), IL - 1\u03b2 , IL - 6 , TNF - \u03b1 , vitamin D and BDNF ."], ["9.405633e-05", "placebo", "vitamin D", "body mass index ( BMI ), body fat percentage , dietary intake and physical activity"], ["0.97545654", "placebo", "vitamin D", "cognitive reactivity to sad mood"], ["0.9500679", "placebo", "vitamin D", "attention - deficit / hyperactivity disorder ( ADHD"]], "sample": "o"}
